Marianne Huben

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

Hematological Malignancy, Medicine, Hematology +6

<i>BCR-ABL</i> Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests

Foluso Ogunleye, Mohammed Ibrahim, Emily Allen et al. · Journal of Oncology Practice · 2016 · 11 citations · Full text

Hematological Malignancy, Polymerase Chain Reaction, Chronic Myeloid Leukemia +14

Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case

Ruby Gupta, Sukhmani Singh, Nwabundo Anusim et al. · European Journal of Case Reports in Internal Medicine · 2021 · 11 citations · Full text

NUT midline lung cancer: a rare case report with literature review

Ruby Gupta, Derek Mumaw, Bana Antonios et al. · AME Case Reports · 2021 · 10 citations · Full text

Surgical Oncology, Rare Case Report, Immunology +16